Real-world evidence: Patient preference of intravenous (IV) vs. subcutaneous (SQ) administration of oncology medications.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-10-01
DOI
https://doi.org/10.1200/op.2025.21.10_suppl.379
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world evidence: Patient preference of intravenous (IV) vs. subcutaneous (SQ) administration of oncology medications.

Qamar J. Khan, Raed Moh’d Taiseer Al-Rajabi, LOUIS DUBOIS, Madalyn Kai Edmonds et al.
JCO Oncology Practice
Pharmaceutical studies and practices
article

Real-world evidence: Patient preference of intravenous (IV) vs. subcutaneous (SQ) administration of oncology medications.

Qamar J. Khan, Raed Moh’d Taiseer Al-Rajabi, LOUIS DUBOIS, Madalyn Kai Edmonds, Nikki Ogle
article en

Abstract

No abstract available for this paper.
JCO Oncology PracticeVol. 21(10_suppl)
University of Kansas (US), The University of Kansas Health System (US), The University of Kansas Cancer Center (US)
Openalex Percentile: Top 60%
Pharmaceutical studies and practices
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.